Related Experiment Videos
Eosinophils as effector cells in immunity and hypersensitivity disorders
Clinical and Experimental Immunology
|October 1, 1985
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Immunosuppression in Chronic Asthma.
International archives of allergy and immunology·2021
The early history of the eosinophil.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014
Calcitonin gene-related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014
Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin.
The British journal of dermatology·2014
Immunotherapy is allergen-specific: a double-blind trial of mite or timothy extract in mite and grass dual-allergic patients.
International archives of allergy and immunology·2012
The silent regulators: Non-Coding RNAs and EBV at the crossroads of Lupus pathogenesis.
Clinical and experimental immunology·2026
Targeting redox imbalance through Nrf2 activation in the inflamed coeliac duodenum.
Clinical and experimental immunology·2026
Dermatomyositis is characterized by TYK2-dependent STAT3 activation.
Clinical and experimental immunology·2026
Helios expression in naïve CD4+ T cells decreases from neonates to older adults.
Clinical and experimental immunology·2026
Could we discuss the molecular signature of immune dysregulation?
Clinical and experimental immunology·2026
The many faces of cytokine storm syndrome: immunopathogenic mechanisms and clinical implications for a better patient management.
Clinical and experimental immunology·2026
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026